時間 | 主題 | ||||
---|---|---|---|---|---|
PD5-1: The effect of BAP1 and PBRM1 mutation on outcomes in patients with clear cell renal cell carcinoma (CCRCC)
講者:
戴盟哲
座長:
溫玉清, 侯鎮邦 |
戴盟哲 |
溫玉清, 侯鎮邦 |
|||
PD5-2: Comparing the value of dap score and renal score for long-term outcomes in robot-assisted partial nephrectomy for renal cell carcinoma patients
講者:
連繼志
座長:
溫玉清, 侯鎮邦 |
連繼志 |
溫玉清, 侯鎮邦 |
|||
PD5-3: Survival benefit after cytoreductive nephrectomy in metastatic renal cell carcinoma: CGMH-LK experience in targeted therapy era
講者:
李承哲
座長:
溫玉清, 侯鎮邦 |
李承哲 |
溫玉清, 侯鎮邦 |
|||
PD5-4: To investigate the duration of initial diagnosis of urothelial cell carcinoma and renal tumor in Taiwan patients with dialysis – a nationwide population-based cohort study
講者:
高建璋
座長:
溫玉清, 侯鎮邦 |
高建璋 |
溫玉清, 侯鎮邦 |
|||
PD5-5: Outcome of patients with T1 renal cell carcinoma received partial nephrectomy: VGHTC experience
講者:
張瓈文
座長:
溫玉清, 侯鎮邦 |
張瓈文 |
溫玉清, 侯鎮邦 |
|||
PD5-6: Modified hand-assisted retroperitoneoscopic nephroureterectomy with an adjunctive port for the treatment of upper urinary tract tumor
講者:
陳義昇
座長:
溫玉清, 侯鎮邦 |
陳義昇 |
溫玉清, 侯鎮邦 |